Carol Aghajanian, MD
Gynecologic Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Cervical Cancer
- Uterine (Endometrial) Cancer
- Gestational Trophoblastic Disease
Request an Appointment
About Me
- Chief, Gynecologic Medical Oncology Service
- Avon Chair in Gynecologic Oncology Research
I am a medical oncologist who focuses exclusively on the medical treatment of gynecologic cancers.
I also lead Memorial Sloan Kettering Cancer Center’s (MSK’s) research program in chemotherapy for patients newly diagnosed with ovarian cancer and have a particular expertise in the management of both advanced gestational trophoblastic disease (GTD) and germ cell tumors of the ovary.
Read more
In addition, I am the co-principal investigator for Memorial Sloan Kettering participation in the Gynecologic Oncology Group (GOG) and serve on the Phase I committee and the Medical Oncology Committee for the GOG.
My recent honors include a career development award from the American Society of Clinical Oncology and the Boyer Award for outstanding young investigators at Memorial Sloan Kettering Cancer Center.
A gynecologic (GY-neh-kuh-LAH-jik) medical oncologist is a cancer doctor who specializes in gynecologic cancers. This includes cervical, fallopian tube, ovarian, uterine (endometrial), vaginal, and vulvar cancers.
My Specialties
- Cervical Cancer
- Uterine (Endometrial) Cancer
- Gestational Trophoblastic Disease
- Ovarian Cancer
Education
- MD, SUNY Health Science Center at Brooklyn
Residencies
- Internal Medicine - Mount Sinai Hospital
Awards and Honors
- Castle Connolly: Exceptional Women in Medicine (2024)
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Exceptional Women in Medicine Award, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2015-2020)
Fellowships
- Medical Oncology/Hematology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Aghajanian sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Aghajanian
- A Phase II/III Study Assessing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2-Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Clinical Trials Co-Investigated by Dr. Aghajanian
- A Phase 2 Study of VS-6766 and Defactinib in People with Advanced Mesonephric Gynecologic Cancer
- A Phase 3 Study of Avutometinib Plus Defactinib Versus Standard Treatment for People With Low-Grade Serous Ovarian Cancer
- A Phase I Study Combining Peposertib (M3814) with Standard Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer
Read more
- A Phase II Study Assessing Radiation Therapy and Cisplatin Chemotherapy for People with Vulvar Cancer in the Sentinel Lymph Nodes
- A Phase III Study Evaluating Less Intensive Ways to Treat Germ Cell Tumors
- A Phase III Study of Accelerated versus Standard Chemotherapy for Patients with Intermediate- and Poor-Risk Metastatic Germ Cell Tumors
- A Phase III Study of Letrozole Alone or with Chemotherapy in Women with Low-Grade Serous Ovarian or Peritoneal Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Aghajanian’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Carol Aghajanian discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities -
GOG Foundation
Fiduciary Role / Position -
Merck & Co Inc.
Professional Services and Activities
-
NRG Oncology
Fiduciary Role / Position -
WCG Oncology
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].